B

Biocon

Request removal

Biocon: Enhancing Global Healthcare Biocon Limited, publicly listed in 2004, is India's largest and fully-integrated, innovation-led biopharmaceutical company. It is an emerging global biopharmaceutical enterprise serving customers in over 120 countries. Driven by a vision to enhance global healthcare through innovative and affordable biopharmaceuticals, we have enabled access to advanced therapies for diseases that are chronic, where medical needs are largely unmet and treatment costs are high. The early anticipation of the increasing dominance of biologics in global development pipelines helped us to be ahead of the curve in crafting a differentiated product portfolio based on fermentation and recombinant technologies, which straddles fermentation-derived small molecules and biologics, both novel as well as biosimilars. The significant brand equity that we have built worldwide for our small molecule APIs across statins, immunosuppresants and other specialty products has made us a leading global supplier of these products. We have also built one of the largest and most diverse biosimilar pipelines, spanning insulins, monoclonal antibodies and other recombinant proteins that address critical chronic diseases such as diabetes, cancer and autoimmune disorders. Ranked among the Top 3 biosimilar players globally for rh-insulin and insulin glargine in volume terms, we are the first Indian company to launch a biosimilar in Japan with Insulin Glargine, which also has been approved for sale in EU and Australia. Our insulin products have made a difference to the lives of millions of people with diabetes across the globe. We now aim to provide our insulin products to ‘one in five' people with diabetes in need of insulin-based therapy anywhere in the world within the next 10 years. We are also making a huge impact in the area of cancer care. Our biosimilar Trastuzumab, which was the first to be approved anywhere in the world and launched in India in 2014, has helped treat several thousand HER2-positive metastatic breast cancer patients. We are also the first company from India to get its biosimilar approved by the USFDA; Ogivri™, co-developed by Biocon and Mylan, is the first biosimilar Trastuzumab to be approved in the US. In addition to Trastuzumab, several of our biosimilar assets are on track for anticipated regulatory approvals in developed markets. We are also developing a pipeline of patented biologics to address global unmet medical needs. We have successfully launched a couple of novel biologics in India: Nimotuzumab for the treatment of head and neck cancer and Itolizumab to tackle psoriasis. Besides these, we have a basket of novel assets are under various stages of clinical development, including a high potential oral insulin. Through our subsidiary, Syngene, we offer a suite of integrated, end-to-end discovery and development services for novel molecular entities (NMEs) to the global life sciences sector. Ranked by the prestigious Science magazine among the Top 10 Best employers in the biotech industry, Biocon is passionately pursuing a mission to rationalize healthcare spends, enhance access to life-saving therapies and make a significant impact to global healthcare through ‘blockbuster' drugs with the potential to benefit a billion patients.

Get valid emails for people working at Biocon and 200M other companies
20 free emails each month. No credit card required.
500M
Business Profiles
20M
Company Profiles
200M
Email addresses
98%+
Email Delivery
Biocon's headquarter address
Line 1: 20th km hosur road electronics city, bengaluru, karnataka, india
Biocon's industries
research
Biocon's technology
Adobe Media Optimizer Apache Bootstrap Framework Cedexis Radar Cloudflare DNS Cloudways Data Analytics Facebook Login (Connect) Facebook Widget Google Analytics Google Font API Google Plus Google Tag Manager Microsoft Azure Microsoft Azure Hosting Microsoft Office 365 Mobile Friendly Outlook Remote Salesforce SuccessFactors (SAP) Ubuntu Vimeo WordPress.org YouTube
People working at Biocon
PD
Prasad S. Deshpande
SVP | Global Head of Procurement, Supply Chain, Contract Manufacturing & Central Engineering
Bengaluru, Karnataka, India
AR
Atanu Roy
Group CIO
KT
Krishna Sai T
Vice President - IT & BRM
Bengaluru, Karnataka, India
NV
Nehal Vora
Senior Vice President Marketing
Bengaluru, Karnataka, India
JV
Jagannathan V
Senior Director Human Resources
Bengaluru, Karnataka, India
IS
Indranil Sen
Chief Financial Officer
Bengaluru, Karnataka, India
AS
Agnidipta Sarkar
Group CISO
Bengaluru, Karnataka, India
JJ
Jesmine S Joseph
Director QMS
Bengaluru, Karnataka, India
TB
Thorsten Biermann
Head Sales & Marketing API - North America
Bengaluru, Karnataka, India
JC
Joyeeta Chatterjee
Vice President Human Resources
Bengaluru, Karnataka, India
You can find 8K+ people working at Biocon on FinalScout. Create a free account to view details including email addresses.
Scrape emails from LinkedIn for free
20 free emails each month. No credit card required.
Regular search results
Search for leads on linkedin.com and scrape the search results
Sales Navigator search results
Search for leads in LinkedIn sales navigator and scrape the search results
Group members
Scrape members from any LinkedIn group without joining it
Event attendees
Scrape event attendees from any LinkedIn event
Directory